FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897476004> ?p ?o ?g. }

• W2897476004 endingPage "933" @default.
• W2897476004 startingPage "923" @default.
• W2897476004 abstract "Objective To identify the level of evidence for use of nusinersen to treat spinal muscular atrophy (SMA) and review clinical considerations regarding use. Methods The author panel systematically reviewed nusinersen clinical trials for patients with SMA and assigned level of evidence statements based on the American Academy of Neurology's 2017 therapeutic classification of evidence scheme. Safety information, regulatory decisions, and clinical context were also reviewed. Results Four published clinical trials were identified, 3 of which were rated above Class IV. There is Class III evidence that in infants with homozygous deletions or mutations of SMN1 , nusinersen improves the probability of permanent ventilation-free survival at 24 months vs a well-defined historical cohort. There is Class I evidence that in term infants with SMA and 2 copies of SMN2 , treatment with nusinersen started in individuals younger than 7 months results in a better motor milestone response and higher rates of event-free survival than sham control. There is Class I evidence that in children aged 2–12 years with SMA symptom onset after 6 months of age, nusinersen results in greater improvement in motor function at 15 months than sham control. Nusinersen was safe and well-tolerated. Clinical context Evidence of efficacy is currently highest for treatment of infantile- and childhood-onset SMA in the early and middle symptomatic phases. While approved indications for nusinersen use in North America and Europe are broad, payer coverage for populations outside those in clinical trials remain variable. Evidence, availability, cost, and patient preferences all influence decision-making regarding nusinersen use." @default.
• W2897476004 created "2018-10-26" @default.
• W2897476004 creator A5028663301 @default.
• W2897476004 creator A5032578156 @default.
• W2897476004 creator A5040407437 @default.
• W2897476004 creator A5041787314 @default.
• W2897476004 creator A5043364831 @default.
• W2897476004 creator A5057657068 @default.
• W2897476004 creator A5064619641 @default.
• W2897476004 date "2018-10-12" @default.
• W2897476004 modified "2023-10-18" @default.
• W2897476004 title "Evidence in focus: Nusinersen use in spinal muscular atrophy" @default.
• W2897476004 cites W1963604250 @default.
• W2897476004 cites W1975560789 @default.
• W2897476004 cites W1992974743 @default.
• W2897476004 cites W2029749457 @default.
• W2897476004 cites W2052064543 @default.
• W2897476004 cites W2107254875 @default.
• W2897476004 cites W2125953041 @default.
• W2897476004 cites W2143197369 @default.
• W2897476004 cites W2153719074 @default.
• W2897476004 cites W2208330709 @default.
• W2897476004 cites W2300951885 @default.
• W2897476004 cites W2304098217 @default.
• W2897476004 cites W2324878797 @default.
• W2897476004 cites W2560202024 @default.
• W2897476004 cites W2583673989 @default.
• W2897476004 cites W2611097996 @default.
• W2897476004 cites W2733659072 @default.
• W2897476004 cites W2750790091 @default.
• W2897476004 cites W2753832341 @default.
• W2897476004 cites W2756239026 @default.
• W2897476004 cites W2767243970 @default.
• W2897476004 cites W2789114047 @default.
• W2897476004 cites W4249822847 @default.
• W2897476004 doi "https://doi.org/10.1212/wnl.0000000000006502" @default.
• W2897476004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30315070" @default.
• W2897476004 hasPublicationYear "2018" @default.
• W2897476004 type Work @default.
• W2897476004 sameAs 2897476004 @default.
• W2897476004 citedByCount "70" @default.
• W2897476004 countsByYear W28974760042018 @default.
• W2897476004 countsByYear W28974760042019 @default.
• W2897476004 countsByYear W28974760042020 @default.
• W2897476004 countsByYear W28974760042021 @default.
• W2897476004 countsByYear W28974760042022 @default.
• W2897476004 countsByYear W28974760042023 @default.
• W2897476004 crossrefType "journal-article" @default.
• W2897476004 hasAuthorship W2897476004A5028663301 @default.
• W2897476004 hasAuthorship W2897476004A5032578156 @default.
• W2897476004 hasAuthorship W2897476004A5040407437 @default.
• W2897476004 hasAuthorship W2897476004A5041787314 @default.
• W2897476004 hasAuthorship W2897476004A5043364831 @default.
• W2897476004 hasAuthorship W2897476004A5057657068 @default.
• W2897476004 hasAuthorship W2897476004A5064619641 @default.
• W2897476004 hasBestOaLocation W28974760041 @default.
• W2897476004 hasConcept C114614502 @default.
• W2897476004 hasConcept C120060458 @default.
• W2897476004 hasConcept C126322002 @default.
• W2897476004 hasConcept C141071460 @default.
• W2897476004 hasConcept C151730666 @default.
• W2897476004 hasConcept C161921814 @default.
• W2897476004 hasConcept C166957645 @default.
• W2897476004 hasConcept C168563851 @default.
• W2897476004 hasConcept C1862650 @default.
• W2897476004 hasConcept C187212893 @default.
• W2897476004 hasConcept C2778558090 @default.
• W2897476004 hasConcept C2779134260 @default.
• W2897476004 hasConcept C2779343474 @default.
• W2897476004 hasConcept C33923547 @default.
• W2897476004 hasConcept C535046627 @default.
• W2897476004 hasConcept C71924100 @default.
• W2897476004 hasConcept C72563966 @default.
• W2897476004 hasConcept C86803240 @default.
• W2897476004 hasConcept C95457728 @default.
• W2897476004 hasConceptScore W2897476004C114614502 @default.
• W2897476004 hasConceptScore W2897476004C120060458 @default.
• W2897476004 hasConceptScore W2897476004C126322002 @default.
• W2897476004 hasConceptScore W2897476004C141071460 @default.
• W2897476004 hasConceptScore W2897476004C151730666 @default.
• W2897476004 hasConceptScore W2897476004C161921814 @default.
• W2897476004 hasConceptScore W2897476004C166957645 @default.
• W2897476004 hasConceptScore W2897476004C168563851 @default.
• W2897476004 hasConceptScore W2897476004C1862650 @default.
• W2897476004 hasConceptScore W2897476004C187212893 @default.
• W2897476004 hasConceptScore W2897476004C2778558090 @default.
• W2897476004 hasConceptScore W2897476004C2779134260 @default.
• W2897476004 hasConceptScore W2897476004C2779343474 @default.
• W2897476004 hasConceptScore W2897476004C33923547 @default.
• W2897476004 hasConceptScore W2897476004C535046627 @default.
• W2897476004 hasConceptScore W2897476004C71924100 @default.
• W2897476004 hasConceptScore W2897476004C72563966 @default.
• W2897476004 hasConceptScore W2897476004C86803240 @default.
• W2897476004 hasConceptScore W2897476004C95457728 @default.
• W2897476004 hasIssue "20" @default.
• W2897476004 hasLocation W28974760041 @default.
• W2897476004 hasLocation W28974760042 @default.
• W2897476004 hasOpenAccess W2897476004 @default.

• next